FrancophonIA/ELRC3.0 huggingface dataset:
English: If you have to undergo surgery whilst taking Rivastigmine 1 A Pharma, you should tell your doctor before you are given any anaesthetics, because Rivastigmine 1 A Pharma may exaggerate the effects of some muscle relaxants during anaesthesia.
Croatian: Ako se, tijekom primjene Rivastigmina 1 A Pharma, morate podvrgnuti operaciji, obavijestite liječnika prije nego što Vam primjeni bilo koji anestetik, jer Rivastigmin 1 A Pharma može tijekom anestezije pojačati učinke nekih mišićnih relaksansa.
English: The efficacy of rivastigmine has been established through the use of three independent, domain specific, assessment tools which were assessed at periodic intervals during 6 month treatment periods.
Croatian: Djelotvornost rivastigmina utvrđena je korištenjem tri neovisne, područno specifične ljestvice za procjenu, koje su upotrebljavane u periodičkim intervalima tijekom razdoblja liječenja od 6
English: Other side effects seen with transdermal patches and which may occur with the hard capsules:
Croatian: Ostale nuspojave primijećene s flasterima za kožu i koje se mogu javiti kod primjene tvrdih kapsula:
English: If the dates for submission of a PSUR and the update of a RMP coincide, they can be submitted at the same time
Croatian: Ako se rokovi podnošenja periodičkog izvješća o neškodljivosti (PSUR) podudaraju s nadopunama Plana (RMP), dokumenti mogu biti podneseni istodobno.
English: What you need to know before you take Rivastigmine 1 A Pharma Do not take Rivastigmine 1 A Pharma
Croatian: Što morate znati prije nego počnete uzimati Rivastigmin 1 A Pharma Nemojte uzimati Rivastigmin 1 A Pharma
English: How to store Rivastigmine 1 A Pharma Contents of the pack and other information
Croatian: Kako čuvati Rivastigmin 1 A Pharma Sadržaj pakiranja i druge informacije
English: Date of first authorization: 11/12/2009 Date of first renewal: 19/08/2014
Croatian: Datum prve obnove: 19.8.2014.
English: What Rivastigmine 1 A Pharma is and what it is used for What you need to know before you take Rivastigmine 1 A Pharma How to take Rivastigmine 1 A Pharma Possible side effects
Croatian: Što je Rivastigmin 1 A Pharma i za što se koristi Što morate znati prije nego počnete uzimati Rivastigmin 1 A Pharma Kako uzimati Rivastigmin 1 A Pharma
English: The PSUR cycle of Rivastigmine 1 A Pharma is aligned with the cross-referred product, Exelon, until otherwise specified.
Croatian: PSUR-evi Ciklus PSURa za Rivastigmin 1 A Pharma usklađen je s referentnim lijekom, Exelonom, ako nije drugačije određeno.
English: The secondary definition of response required a 4--point or greater improvement on the ADAS-Cog, no worsening on the CIBIC-Plus, and no worsening on the PDS.
Croatian: Za sekundarnu je definiciju odgovora bilo potrebno poboljšanje od 4 boda ili više na ADAS-Cog ljestvici, nikakvo pogoršanje na CIBIC-Plus ljestvici te nikakvo pogoršanje na PDS ljestvici.
English: If you forget to take Rivastigmine 1 A Pharma
Croatian: Ako ste zaboravili uzeti Rivastigmin 1 A Pharma
English: The mean actual daily dose for responders in the 6-12 mg group, corresponding to this definition, was 9.3 mg.
Croatian: 6-12 mg, prema ovoj definiciji, bila je 9,3 mg.
English: They are packed in blisters available in three different pack sizes (28, 56 or 112 capsules) and plastic bottles of 250 capsules, but these may not all be available in your country.
Croatian: kapsula) i plastičnim bočicama od 250 kapsula, no ta pakovanja možda nisu dostupna u Vašoj zemlji.
English: Rivastigmine 1 A Pharma should not be given at the same time as other medicines with similar effects to Rivastigmine 1 A Pharma.
Croatian: Rivastigmin 1 A Pharma ne smije se davati istodobno s drugim lijekovima sa sličnim djelovanjem Rivastigminu 1 A Pharma.
English: Rivastigmine 1 A Pharma belongs to a class of substances called cholinesterase inhibitors.
Croatian: Rivastigmnin pripada skupini tvari koje se nazivaju inhibitori kolinesteraze.
English: Rivastigmine 1 A Pharma 1.5 mg hard capsules Rivastigmine 1 A Pharma 3 mg hard capsules Rivastigmine 1 A Pharma 4.5 mg hard capsules Rivastigmine 1 A Pharma 6 mg hard capsules
Croatian: Rivastigmin 1 A Pharma 1,5 mg tvrde kapsule Rivastigmin 1 A Pharma 3 mg tvrde kapsule Rivastigmin 1 A Pharma 4,5 mg tvrde kapsule Rivastigmin 1 A Pharma 6 mg tvrde kapsule rivastigmin
English: • Urinary incontinence (inability to retain adequate urine) Uncommon (may affect up to 1 in 100 people)
Croatian: • Urinarna inkontinencija (nemogućnost adekvatnog zadržavanja urina)
English: Keep this medicine out of the sight and reach of children.
Croatian: Čuvati lijek izvan dohvata i pogleda djece.
English: Use Rivastigmine 1 A Pharma oral solution within 1 month of opening the bottle.
Croatian: Oralnu otopinu Rivastigmin 1 A Pharma upotrijebite u roku od 1 mjesec od otvaranja bočice.
English: What Rivastigmine 1 A Pharma looks like and contents of the pack
Croatian: Kako Rivastigmin 1 A Pharma izgleda i sadržaj pakovanja
English: Initial dose 1.5 mg twice a day.
Croatian: 1,5 mg dva puta na dan.
English: You should not breast-feed during treatment with Rivastigmine 1 A Pharma.
Croatian: Ne smijete dojiti tijekom liječenja Rivastigminom 1 A Pharma.
English: • Take Rivastigmine 1 A Pharma twice a day, in the morning and evening, with food.
Croatian: • Trebate uzimati Rivastigmin 1 A Pharma dva puta na dan, ujutro i uvečer uz obrok.
English: There have been rare post-marketing reports of patients experiencing allergic dermatitis (disseminated) when administered rivastigmine irrespective of the route of administration (oral, transdermal).
Croatian: Postojala su rijetka iskustva s alergijskim dermatitisom (diseminiranim) u bolesnika nakon stavljanja lijeka u promet kod primjene rivastigmina bez obzira na put primjene (peroralno,
English: Other medicines and Rivastigmine 1 A Pharma
Croatian: Drugi lijekovi i Rivastigmin 1 A Pharma
English: Other side effects seen with transdermal patches and which may occur with the oral solution:
Croatian: Ostale nuspojave primijećene s flasterima za kožu i koje se mogu javiti kod primjene oralne otopine:
English: 3 years Rivastigmine 1 A Pharma oral solution should be used within 1 month of opening the bottle.
Croatian: Oralnu otopinu Rivastigmin 1 A Pharma treba upotrijebiti u roku od 1 mjesec od otvaranja bočice.
English: CARTON FOR HDPE BOTTLE LABEL FOR HDPE BOTTLE
Croatian: NALJEPNICA ZA HDPE BOČICU
English: Since bradycardia constitutes a risk factor in the occurrence of torsades de pointes, the combination of rivastigmine with torsades de pointes-inducing medicinal products such as antipsychotics i.e. some phenothiazines (chlorpromazine, levomepromazine), benzamides (sulpiride, sultopride, amisulpride, tiapride, veralipride), pimozide, haloperidol, droperidol, cisapride, citalopram, diphemanil, erythromycin IV, halofantrin, mizolastin, methadone, pentamidine and moxifloxacine should be observed with caution and clinical monitoring (ECG) may also be required.
Croatian: S obzirom da bradikardija predstavlja rizik za pojavu torsades de pointes, kombinacija rivastigmina s lijekovima koji izazivaju torsades de pointes kao što su antipsihotici tj. neki fenotiazini (klorpromazin, levomepromazin), benzamidi (sulpirid, sultoprid, amisulprid, tiaprid, veraliprid), pimozid, haloperidol, droperidol, cisaprid, citalopram, difemanil, eritromicin IV, halofantrin, mizolastin, metadon, pentamidin i moksifloksacin mora se pažljivo pratiti te također može biti potrebno kliničko praćenje (EKG).
English: Important information about some of the ingredients of Rivastigmine 1 A Pharma
Croatian: Važni podaci o nekim sastojcima Rivastigmina 1 A Pharma
English: Do not use Rivastigmine 1 A Pharma after the expiry date which is stated on the carton.
Croatian: Rivastigmin 1 A Pharma se ne smije upotrijebiti nakon isteka roka valjanosti navedenog na kutiji.
English: even if their signs of illness s are the same as yours.
Croatian: Može im naškoditi, čak i ako su njihovi znakovi bolesti jednaki Vašima.
English: There is no relevant use of Rivastigmine 1 A Pharma in the paediatric population in the treatment of Alzheimer's disease.
Croatian: Ne postoji značajna primjena Rivastigmina 1 A Pharma u pedijatrijskoj populaciji kod liječenja
English: If you take more Rivastigmine 1 A Pharma than you should
Croatian: Ako uzmete više kapsula Rivastigmin 1 A Pharma nego što ste trebali
English: Cholinergic toxicity has been reported with muscarinic symptoms that are observed with moderate poisonings such as miosis, flushing, digestive disorders including abdominal pain, nausea, vomiting and diarrhoea, bradycardia, bronchospasm and increased bronchial secretions, hyperhidrosis, involuntary urination and/or defecation, lacrimation, hypotension and salivary hypersecretion.
Croatian: Kolinergička toksičnost zabilježena je s muskarinskim simptomima koji su tipični za umjereno trovanje poput mioze, rumenila, probavnih poremećaja, uključujući bol u trbuhu, mučninu, povraćanje i proljev, bradikardije, bronhospazma i povećane bronhijalne sekrecije, hiperhidroze, nehotičnog mokrenja i/ili defekacije, suzenja, hipotenziju i hipersekreciju sline.
English: • Tell your caregiver that you are taking Rivastigmine 1 A Pharma.
Croatian: • Recite osobi koja Vas njeguje da uzimate Rivastigmin 1 A Pharma.
English: Rivastigmine 1 A Pharma 3 mg and 6 mg hard capsules:
Croatian: Rivastigmin 1 A Pharma 3 mg i 6 mg tvrde kapsule:
English: One of the inactive ingredients in Rivastigmine 1 A Pharma oral solution is sodium benzoate.
Croatian: Jedan od neaktivnih sastojaka oralne otopine Rivastigmin 1 A Pharma je natrijev benzoat.
English: Date of first authorisation: 11/12/2009 Date of first renewal: 19/08/2014
Croatian: Datum prvog odobrenja: 11.12.2009.
English: - Capsule fill: - Microcrystalline cellulose - Magnesium stearate - Hypromellose - Silica, colloidal anhydrous
Croatian: - magnezijev stearat - hipromeloza - silicijev dioksid, koloidni, bezvodni
English: If you are pregnant, the benefits of using Rivastigmine 1 A Pharma must be assessed against the possible effects on your unborn child. Rivastigmine 1 A Pharma should not be used during pregnancy unless clearly necessary.
Croatian: Ako ste trudni, koristi primjene Rivastigmina 1 A Pharma moraju se procijeniti u odnosu na moguće djelovanje na nerođeno dijete.
English: The active substance of Rivastigmine 1 A Pharma is rivastigmine.
Croatian: Djelatna tvar Rivastigmina 1 A Pharma je rivastigmin.
English: D. CONDITIONS OR RESTRICTIONS WITH REGARDS TO THE SAFE AND EFFECTIVE USE OF THE MEDICINAL PRODUCT
Croatian: UVJETI ILI OGRANIČENJA VEZANI UZ SIGURNU I UČINKOVITU
English: How to take Rivastigmine 1 A Pharma
Croatian: Kako uzimati Rivastigmin 1 A Pharma
English: One of the excipients in Rivastigmine 1 A Pharma oral solution is sodium benzoate.
Croatian: Jedna od pomoćnih tvari oralne otopine Rivastigmin 1 A Pharma je natrijev benzoat.
English: Package leaflet: Information for the patient Rivastigmine 1 A Pharma 2 mg/ml oral solution
Croatian: Uputa o lijeku: Informacija za bolesnika Rivastigmin 1 A Pharma 2 mg/ml oralna otopina rivastigmin
English: Rivastigmine 1 A Pharma 2 mg/ml oral solution
Croatian: Rivastigmin 1 A Pharma 2 mg/ml oralna otopina
English: Rivastigmine 1 A Pharma might interfere with anticholinergic medicines (medicines used to relieve stomach cramps or spasms, to treat Parkinson's disease or to prevent travel sickness).
Croatian: (lijekove koji se koriste za ublažavanje grčeva ili spazama u želucu, za liječenje Parkinsonove bolesti ili za sprečavanje mučnine na putovanju).
English: Rivastigmine 1 A Pharma 1.5 mg hard capsules:
Croatian: Rivastigmin 1 A Pharma 1,5 mg tvrde kapsule:
English: Rivastigmine 1 A Pharma 6 mg
Croatian: Rivastigmin 1 A Pharma 6 mg
English: Each Rivastigmine 1 A Pharma 6 mg capsule contains 6 mg of rivastigmine.
Croatian: Svaka kapsula Rivastigmina 1 A Pharma od 6 mg sadrži 6 mg rivastigmina.
English: Rivastigmine 1 A Pharma 3 mg
Croatian: Rivastigmin 1 A Pharma 3 mg
English: How to store Rivastigmine 1 A Pharma
Croatian: Kako čuvati Rivastigmin 1 A Pharma
English: Each Rivastigmine 1 A Pharma 4.5 mg capsule contains 4.5 mg of rivastigmine.
Croatian: Svaka kapsula Rivastigmina 1 A Pharma od 4,5 mg sadrži 4,5 mg rivastigmina.
English: Each Rivastigmine 1 A Pharma 3 mg capsule contains 3 mg of rivastigmine.
Croatian: Svaka kapsula Rivastigmina 1 A Pharma od 3 mg sadrži 3 mg rivastigmina.
English: Each Rivastigmine 1 A Pharma 1.5 mg capsule contains 1.5 mg of rivastigmine.
Croatian: Svaka kapsula Rivastigmina 1 A Pharma od 1,5 mg sadrži 1,5 mg rivastigmina.
English: Some people who have accidentally taken too much Rivastigmine 1 A Pharma have experienced feeling sick (nausea), being sick (vomiting), diarrhoea, high blood pressure and hallucinations.
Croatian: Pharma su osjećali mučninu, povraćali, imali proljev, visoki krvni tlak i halucinacije.
English: Rivastigmine 1 A Pharma 4.5 mg
Croatian: Rivastigmin 1 A Pharma 4,5 mg
English: Rivastigmine 1 A Pharma 4.5 mg hard capsules:
Croatian: Rivastigmin 1 A Pharma 4,5 mg tvrde kapsule:
English: Clinically relevant improvement in these studies was defined a priori as at least 4-point improvement on the ADAS-Cog, improvement on the CIBIC-Plus, or at least a 10% improvement on the PDS.
Croatian: 4 boda na ADAS-Cog ljestvici, poboljšanje na CIBIC-Plus ili poboljšanje od najmanje 10% na PDS ljestvici.
English: Rivastigmine 1 A Pharma 1.5 mg
Croatian: Rivastigmin 1 A Pharma 1,5 mg
English: Each ml contains rivastigmine hydrogen tartrate corresponding to 2mg rivastigmine.
Croatian: Svaki ml sadrži rivastigmin hidrogentartarat koji odgovara 2 mg rivastigmina.
English: • Allergic reaction where the patch was used, such as blisters or skin inflammation If you get any of these side effects, contact your doctor as you may need medical assistance.
Croatian: • Alergijska reakcija kod primjene flastera, kao što su plikovi ili upala kože
English: Each capsule contains rivastigmine hydrogen tartrate corresponding to 6 mg rivastigmine.
Croatian: Svaka kapsula sadrži rivastigmin hidrogentartarat koji odgovara 6 mg rivastigmina.
English: Rivastigmine 1 A Pharma 2 mg/ml oral solution rivastigmine (as hydrogen tartrate)
Croatian: Rivastigmin 1 A Pharma 2 mg/ml oralna otopina rivastigmin (u obliku rivastigmin hidrogentartarata)
English: Only for carton box: Rivastigmine 1 A Pharma 2 mg/ml
Croatian: Samo za kartonsku kutiju: Rivastigmin 1 A Pharma 2 mg/ml
English: - Rivastigmine 1 A Pharma 1.5 mg hard capsules, which contain an off-white to slightly yellow powder, have a yellow cap and yellow body, with a red imprint “RIV 1.5 mg” on the body.
Croatian: - Rivastigmin 1 A Pharma 1,5 mg tvrde kapsule, koje sadrže bjelkasti do žućkasti prašak, imaju žutu kapicu i žuto tijelo s crvenom oznakom „RIV 1,5 mg“.
English: Only for carton box: Rivastigmine 1 A Pharma 6 mg
Croatian: Samo za kartonsku kutiju: Rivastigmin 1 A Pharma 6 mg
English: Rivastigmine 1 A Pharma 4.5 mg hard capsules rivastigmine (as hydrogen tartrate)
Croatian: Rivastigmin 1 A Pharma 4,5 mg tvrde kapsule rivastigmin (u obliku rivastigmin hidrogentartarata)
English: Rivastigmine 1 A Pharma 6 mg hard capsules rivastigmine (as hydrogen tartrate)
Croatian: Rivastigmin 1 A Pharma 6 mg tvrde kapsule rivastigmin (u obliku rivastigmin hidrogentartarata)
English: Only for carton box: Rivastigmine 1 A Pharma 4.5 mg
Croatian: Samo za kartonsku kutiju: Rivastigmin 1 A Pharma 4,5 mg
English: Rivastigmine 1 A Pharma oral solution is supplied as 50 ml or 120 ml of a clear, yellow solution (2.0 mg/ml base) in an amber glass bottle with a child-resistant cap, foam liner, dip tube and self aligning plug.
Croatian: Oralna otopina Rivastigmin 1 A Pharma isporučuje se kao bistra, žuta otopina od 50 ml ili 120 ml
English: Only for carton box: Rivastigmine 1 A Pharma 1.5 mg
Croatian: Samo za kartonsku kutiju: Rivastigmin 1 A Pharma 1,5 mg
English: - Rivastigmine 1 A Pharma 4.5 mg hard capsules, which contain an off-white to slightly yellow powder, have a red cap and red body, with a white imprint “RIV 4.5 mg” on the body.
Croatian: - Rivastigmin 1 A Pharma 4,5 mg tvrde kapsule, koje sadrže bjelkasti do žućkasti prašak, imaju crvenu kapicu i crveno tijelo s bijelom oznakom „RIV 4,5 mg“.
English: Rivastigmine 1 A Pharma 6 mg hard capsules: EU/1/09/585/013
Croatian: Rivastigmin 1 A Pharma 6 mg tvrde kapsule: EU/1/09/585/013
English: Only for carton box: Rivastigmine 1 A Pharma 3 mg
Croatian: Samo za kartonsku kutiju: Rivastigmin 1 A Pharma 3 mg
English: Rivastigmine 1 A Pharma 3 mg hard capsules rivastigmine (as hydrogen tartrate)
Croatian: Rivastigmin 1 A Pharma 3 mg tvrde kapsule rivastigmin (u obliku rivastigmin hidrogentartarata)
English: - Rivastigmine 1 A Pharma 6 mg hard capsules, which contain an off-white to slightly yellow powder, have a red cap and orange body, with a red imprint “RIV 6 mg” on the body.
Croatian: - Rivastigmin 1 A Pharma 6 mg tvrde kapsule, koje sadrže bjelkasti do žućkasti prašak, imaju crvenu kapicu i narančasto tijelo s crvenom oznakom „RIV 6 mg“.
English: Rivastigmine 1 A Pharma 1.5 mg hard capsules rivastigmine (as hydrogen tartrate)
Croatian: Rivastigmin 1 A Pharma 1,5 mg tvrde kapsule rivastigmin (u obliku rivastigmin hidrogentartarata)
English: In other cases, rivastigmine has been discontinued (see section 4.8).
Croatian: U takvim slučajevima liječenje treba prekinuti (vidjeti dio 4.3).
English: Rivastigmine 1 A Pharma 4.5 mg hard capsules: EU/1/09/585/009
Croatian: Rivastigmin 1 A Pharma 4,5 mg tvrde kapsule: EU/1/09/585/009
English: Rivastigmine 1 A Pharma 3 mg hard capsules: EU/1/09/585/005
Croatian: Rivastigmin 1 A Pharma 3 mg tvrde kapsule: EU/1/09/585/005
English: Rivastigmine 1 A Pharma 1.5 mg hard capsules: EU/1/09/585/001
Croatian: Rivastigmin 1 A Pharma 1,5 mg tvrde kapsule: EU/1/09/585/001
English: - Rivastigmine 1 A Pharma 3 mg hard capsules, which contain an off-white to slightly yellow powder, have an orange cap and orange body, with a red imprint “RIV 3 mg” on the body.
Croatian: - Rivastigmin 1 A Pharma 3 mg tvrde kapsule , koje sadrže bjelkasti do žućkasti prašak, imaju narančastu kapicu i narančasto tijelo s crvenom oznakom „RIV 3 mg“.
English: Table 3 lists the number and percentage of patients from the specific 24-week clinical study conducted with rivastigmine in patients with dementia associated with Parkinson's disease with pre-defined adverse events that may reflect worsening of parkinsonian symptoms.
Croatian: tjedna, provedenog s rivastigminom u bolesnika s demencijom povezanom s Parkinsonovom bolešću, pri čemu su nuspojave, koje bi mogle odražavati pogoršanje simptoma parkinsonizma, bile unaprijed definirane.
English: Dementia associated with Parkinson's Disease
Croatian: Parkinsonovom bolešću
English: Parkinsonism
Croatian: Parkinsonove bolesti)
English: Each ml contains 2.0 mg of rivastigmine (as hydrogen tartrate).
Croatian: Svaki ml sadrži 2 mg rivastigmina u obliku rivastigmin hidrogentartarata.
English: Patients with clinically significant renal or hepatic impairment might experience more adverse reactions (see sections 4.2 and 5.2).
Croatian: Nisu proučavani bolesnici s teškim oštećenjem jetre, no kapsule rivastigmina mogu se koristiti u ovoj populaciji bolesnika uz pažljivo praćenje (vidjeti dijelove 4.4 i 5.2).
English: - if you have, or have ever had impaired kidney function.
Croatian: - ako imate ili ste imali nepravilne ili spore otkucaje srca,
English: Date of first authorisation: 18 January 2018
Croatian: Datum prvog odobrenja: 18. siječnja 2018.
English: Type AE
Croatian: Tip AE
English: Type C
Croatian: Tip C
English: HIV PI darunavir amprenavir atazanavir indinavir lopinavir saquinavir tipranavir
Croatian: Inhibitori proteaze (IP) darunavir amprenavi atazanavir indinavir lopinavir sakvinavir tipranavir
English: TAD Pharma GmbH Heinz-Lohmann-Straβe 5 27472 Cuxhaven Germany
Croatian: TAD Pharma GmbH Heinz-Lohmann-Straβe 5 27472 Cuxhaven Njemačka
English: Cobicistat is not indicated for use in twice daily regimens or for use in the paediatric population.
Croatian: Kobicistat nije indiciran za primjenu u režimu doziranja dvaput na dan ili za primjenu u pedijatrijskoj populaciji.
English: Ethinylestradiol/drospirenone.
Croatian: - etinilestradiol/drospirenon.
English: Metformin (to treat type 2 diabetes).
Croatian: - metformin (za liječenje šećerne bolesti tipa 2).
English: Take two 400 milligram tablets at the same time or one 800 miligram tablet, once a day, every day.
Croatian: - Uzimite dvije tablete od 400 miligrama u isto vrijeme ili jednu tabletu od 800 miligrama, jedanput na dan, svaki dan.
English: section 4.3).
Croatian: (vidjeti dio 4.3).
English: The effects of Darunavir Krkad.d.might be reduced if you take any of the following products.
Croatian: Učinci lijeka Darunavir Krka d.d. mogu se smanjiti ako uzimate bilo koji od sljedećih lijekova.
English: If you belong to this age group, please discuss with your doctor if you can use Darunavir Krka d.d..
Croatian: Ako pripadate toj dobnoj skupini, molimo Vas da s liječnikom razmotrite smijete li uzimati lijek Darunavir Krka d.d.
English: The dose of cobicistat to be used with darunavir has not been established in this patient population.
Croatian: Doza kobicistata koja se uzima s darunavirom nije bila ustanovljena u ovoj populaciji bolesnika.
English: Of the 44 patients taking ritonavir oral solution, 27 switched to the 100 mg capsule formulation and exceeded the weight based ritonavir dose without changes in observed safety.
Croatian: Od 44 bolesnika koji su uzimali ritonavir oralnu otopinu, njih 27 prešlo je na 100 mg kapsule i time prešlo preporučeno doziranje na temelju tjelesne težine, a da pri tome nisu opažene promjene u sigurnosti.
English: Darunavir/ritonavir should be used during pregnancy only if the potential benefit justifies the potential risk (see sections 4.4, 4.6 and 5.2).
Croatian: Darunavir/ritonavir se smiju uzimati tijekom trudnoće samo ako potencijalna korist opravdava potencijalni rizik (vidjeti dijelove 4.4, 4.6 i 5.2).
English: Darunavir Krka d.d.might increase sugar levels in the blood.
Croatian: Darunavir Krka d.d. može povisiti razine šećera u krvi.
English: When used for birth control, alternative methods of nonhormonal contraception are recommended.
Croatian: Za zaštitu od začeća, preporučuju se drugi oblici nehormonske kontracepcije.
English: INTERACTIONS AND DOSE RECOMMENDATIONS WITH OTHER MEDICINAL PRODUCTS
Croatian: INTERAKCIJE I PREPORUČENE DOZE S DRUGIM LIJEKOVIMA
English: Warnings and precautions Talk to your doctor, pharmacist or nurse before taking Darunavir Krka d.d..
Croatian: Obratite se svom liječniku, ljekarniku ili medicinskoj sestri prije nego uzmete Darunavir Krka d.d.
English: withany of the following medicines If you are taking any of these, ask your doctor about switching to another medicine.
Croatian: Ako uzimate neki od navedenih lijekova, pitajte svog liječnika o prebacivanju na drugi lijek.
English: What you need to know before you take Darunavir Krka d.d.
Croatian: Što morate znati prije nego počnete uzimati Darunavir Krka d.d.
English: PHOSPHODIESTERASE, TYPE 5 (PDE-5) INHIBITORS For the treatment of erectile dysfunction
Croatian: INHIBITORI FOSFODIESTERAZE, TIP 5 (PDE-5) Za liječenje erektilne disfunkcije Avanafil
English: What Darunavir Krka d.d.looks like and contents of the pack Darunavir Krka d.d.400mg film-coated tablets (tablets):
Croatian: Kako Darunavir Krka d.d. izgleda i sadržaj pakiranja Darunavir Krka d.d. 400 mg filmom obložene tablete (tablete):
English: cannot work properly without cobicistat or ritonavir and food.
Croatian: Darunavir Krka d.d. ne može pravilno djelovati bez kobicistata ili ritonavira i hrane.
English: Darunavir demonstrates antiviral activity in vitroagainst a broad panel of HIV-1 group M (A, B, C, D, E, F, G) and group O primary isolates with EC50values ranging from < 0.1 to 4.3 nM.
Croatian: Darunavir pokazuje antivirusnu aktivnost in vitro protiv širokog panela HIV-1 skupine M (A, B, C, D, E, F, G) i skupine O primarno izolata s EC50 vrijednostima u rasponu od < 0,1 do 4,3 nM.
English: with food and drink See section 3 ‘How to take Darunavir Krka d.d..'
Croatian: Darunavir Krka d.d. s hranom i pićem Vidjeti dio 3 „Kako uzimati Darunavir Krka d.d.“
English: 600 mg film coated tablets must not be chewed or crushed.
Croatian: Darunavir Krka d.d. 600 mg filmom obložene tablete ne smiju se žvakati ili lomiti.